Maryland Health Care Product Development Corporation (MHCPDC) is a supporting organization of the Tech Council of Maryland (TCM). Its goal is to stimulate growth of the biomedical industry in the state through “early stage” investment with promising Maryland biomedical and medical technology companies. The Corporation will support TCM’s work in Maryland and the region by assisting emerging companies with management advice, market research, technical assessments and “early stage†financing.
| Company | Date | Round | Size | Participants |
| Corridor Pharmaceuticals | 6/10 | Series A | $15M | 8 |
| Arginetix | 11/09 | Series B | $4.6M | 5 |
